Romualdo Barroso-Sousa
Romualdo Barroso-Sousa
Clinical Fellow, Dana-Farber Cancer Institute
Подтвержден адрес электронной почты в домене
Incidence of endocrine dysfunction following the use of different immune checkpoint inhibitor regimens: a systematic review and meta-analysis
R Barroso-Sousa, WT Barry, AC Garrido-Castro, FS Hodi, L Min, IE Krop, ...
JAMA oncology 4 (2), 173-182, 2018
Wnt/beta-catenin pathway: modulating anticancer immune response
SG Pai, BA Carneiro, JM Mota, R Costa, CA Leite, R Barroso-Sousa, ...
Journal of hematology & oncology 10 (1), 1-12, 2017
Neutrophil extracellular traps induce organ damage during experimental and clinical sepsis
PG Czaikoski, JMSC Mota, DC Nascimento, F Sônego, FVS Castanheira, ...
PloS one 11 (2), e0148142, 2016
Endocrine toxicity of cancer immunotherapy targeting immune checkpoints
LS Chang, R Barroso-Sousa, SM Tolaney, FS Hodi, UB Kaiser, L Min
Endocrine reviews 40 (1), 17-65, 2019
Comprehensive cancer-gene panels can be used to estimate mutational load and predict clinical benefit to PD-1 blockade in clinical practice
LF Campesato, R Barroso-Sousa, L Jimenez, BR Correa, J Sabbaga, ...
Oncotarget 6 (33), 34221, 2015
Sleep disturbances in patients on maintenance hemodialysis: role of dialysis shift
JPC Bastos, RB Sousa, LAM Nepomuceno, OA Gutierrez-Adrianzen, ...
Revista da Associação Médica Brasileira 53 (6), 492-496, 2007
Characterization of thyroid disorders in patients receiving immune checkpoint inhibition therapy
H Lee, FS Hodi, A Giobbie-Hurder, PA Ott, EI Buchbinder, R Haq, ...
Cancer immunology research 5 (12), 1133-1140, 2017
Differences between invasive lobular and invasive ductal carcinoma of the breast: results and therapeutic implications
R Barroso-Sousa, O Metzger-Filho
Therapeutic advances in medical oncology 8 (4), 261-266, 2016
Clinical development of the CDK4/6 inhibitors ribociclib and abemaciclib in breast cancer
R Barroso-Sousa, GI Shapiro, SM Tolaney
Breast care 11 (3), 167-173, 2016
Prevalence and mutational determinants of high tumor mutation burden in breast cancer
R Barroso-Sousa, E Jain, O Cohen, D Kim, J Buendia-Buendia, E Winer, ...
Annals of Oncology 31 (3), 387-394, 2020
Endocrine dysfunction induced by immune checkpoint inhibitors: Practical recommendations for diagnosis and clinical management
R Barroso‐Sousa, PA Ott, FS Hodi, UB Kaiser, SM Tolaney, L Min
Cancer 124 (6), 1111-1121, 2018
Tumor mutational burden and PTEN alterations as molecular correlates of response to PD-1/L1 blockade in metastatic triple-negative breast cancer
R Barroso-Sousa, TE Keenan, S Pernas, P Exman, E Jain, ...
Clinical Cancer Research 26 (11), 2565-2572, 2020
Adhesion molecules and Differentiation Syndrome: phenotypic and functional analysis of the effect of ATRA, As2O3, phenylbutyrate, and G-CSF in acute promyelocytic leukemia
GC De Santis, M de Barros Tamarozzi, RB Sousa, SE Moreno, D Secco, ...
haematologica 92 (12), 1615-1622, 2007
Glutamine and alanyl-glutamine accelerate the recovery from 5-fluorouracil-induced experimental oral mucositis in hamster
RFC Leitão, RA Ribeiro, AMS Lira, LR Silva, EAL Bellaguarda, ...
Cancer chemotherapy and pharmacology 61 (2), 215-222, 2008
Severe paraquat poisoning: clinical and radiological findings in a survivor
FF Neves, RB Sousa, A Pazin-Filho, P Cupo, J Elias Júnior, ...
Jornal Brasileiro de Pneumologia 36, 513-516, 2010
Pre-treatment neutrophil-to-lymphocyte ratio affects survival in patients with advanced hepatocellular carcinoma treated with sorafenib
LG Da Fonseca, R Barroso-Sousa, ASA Bento, BP Blanco, GL Valente, ...
Medical oncology 31 (11), 264, 2014
Vatairea macrocarpa (Leguminosae) lectin activates cultured macrophages to release chemotactic mediators
NMN Alencar, AMS Assreuy, A Havt, RG Benevides, TR de Moura, ...
Naunyn-Schmiedeberg's archives of pharmacology 374 (4), 275-282, 2007
Neoadjuvant endocrine therapy in breast cancer: current role and future perspectives
R Barroso-Sousa, DDAFR Silva, JVM Alessi, MS Mano
Ecancermedicalscience 10, 2016
Complete resolution of hypercortisolism with sorafenib in a patient with advanced medullary thyroid carcinoma and ectopic ACTH (adrenocorticotropic hormone) syndrome
R Barroso-Sousa, AM Lerario, J Evangelista, C Papadia, DM Lourenço Jr, ...
Thyroid 24 (6), 1062-1066, 2014
Optimal treatment of early stage HER2‐positive breast cancer
S Pernas, R Barroso‐Sousa, SM Tolaney
Cancer 124 (23), 4455-4466, 2018
В данный момент система не может выполнить эту операцию. Повторите попытку позднее.
Статьи 1–20